Photo of Ernst R. Berndt, PhD

Selected Expertise

  • Antitrust analysis
  • Damages and liability analysis
  • Econometrics
  • Healthcare economics
  • Industrial organization
  • Intellectual property
  • Market analysis and research
  • Patent infringement
  • Pharmaceutical pricing and reimbursement
  • Pricing policy
  • Regulatory policy analysis
  • Sampling analysis
  • Statistical analysis

Selected Industries

  • Biotechnology
  • Computer hardware and software
  • Health insurance
  • Healthcare
  • Medicare and Medicaid
  • Pharmaceuticals

Ernst R. Berndt, PhD

Profile
Events

Ernst R. Berndt is the Louis E. Seley Chaired Professor in Applied Economics at the Alfred P. Sloan School of Management, Massachusetts Institute of Technology. Since 2000 he has also been a member of the Federal Economic Statistics Advisory Committee and from 2000 to 2004 was its first Chair. Currently he chairs the Bureau of Economic Analysis Advisory Council. During the last decade he has been a special government employee at the Food and Drug Administration, Office of the Commissioner. In 2012 Dr. Berndt was named Chair of the Medicare Economic Index Technical Advisory Panel at the Office of the Actuary, Center for Medicare and Medicaid Services.

From 2004 through 2013, Dr. Berndt served as Co-Director of the Harvard-MIT Division of Health Sciences Biomedical Enterprise Program, and from 1999 through 2010 as Director of the National Bureau of Economic Research Program on Technological Progress and Productivity Measurement. He also has served several terms as a Panel Member of the National Science Foundation Panel on Measurement, Methodology and Statistics.

Professor Berndt has served as an expert economic witness in litigation matters involving the software, computer hardware, biopharmaceutical, and diagnostics industries. Among notable cases he has worked on are United States v. Microsoft, Novartis Pharmaceutials Corporation v. Teva Pharmaceuticals USA, and Amgen Inc. v. Sanofi-Aventis and Regeneron Pharmaceuticals. He was appointed an Independent Expert to the Court in the Pharmaceutical Industry Average Wholesale Price Litigation MDL and in Amgen v. Hoffman LaRoche. His expert reports and testimony have addressed issues involving damage estimates, Paragraph IV disputes, “pay-for-delay,” irreparable harm from injunctions, “product hopping,” and breach of contract matters.

In the last decade, much of Dr. Berndt’s research has focused on economic issues in healthcare, with a strong emphasis on the measurement of costs, outcomes, and prices. He has published more than 220 peer-reviewed articles. His healthcare research has been published in peer-reviewed journals such as the New England Journal of Medicine, Journal of Health Economics, Health Affairs, Annals of Internal Medicine, and American Economic Review. Outside of healthcare, he has published in peer-reviewed journals such as Econometrica, Journal of Econometrics, Review of Economics and Statistics, and Review of Economic Studies.

Education

PhD, Economics, University of Wisconsin–Madison

PhD (honorary), Uppsala University, Sweden

PhD (honorary), University of Basel, Switzerland

MS, Public finance, University of Wisconsin–Madison

BA (with honors), Economics, Philosophy, Valparaiso University